Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. (Q34329621)
Jump to navigation
Jump to search
scientific article
- Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. |
scientific article |
|
Statements
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine (English)
R Baldwin
P Bentham
C Katona
C Lawton
J Lindesay
N McCrae
E Moniz-Cook
J Murray
S Nurock
M Orrell
M Poppe
A Thomas
R Walwyn
1 February 2013